A Novel APOC2 Mutation in a Colombian Patient with Recurrent Hypertriglyceridemic Pancreatitis

References

• González-Juanatey JR, Millán J, Alegría E, Guijarro C, Lozano JV, Vitale GC. Prevalence and characteristics of lipid abnormalities in patients treated with statins in primary and secondary prevention in Spain. DYSIS-Spain Study. Rev Esp Cardiol. 2011;64(4):286–294. doi:10.1016/j.recesp.2010.10.030
   PubMed Web of Science ®Google Scholar
• Galvis-Pérez Y, Barona-Acevedo J, Arias-Cardona A-J. Prevalence of dyslipidemia in a health services provider institution of medellin (Colombia), 2013. CES Medicina. 2016;30(1):3–13. doi:10.21615/cesmedicina.30.1.1
   Google Scholar
• Zhang M, Deng Q, Wang L, et al. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: a nationally representative survey of 163,641 adults. Int J Cardiol. 2018;1(260):196–203.
   Google Scholar
• Munguía-Miranda C, Sánchez-Barrera RG, Hernández-Saavedra D, Cruz-López M. Dyslipidemia prevalence and its relationship with insulin resistance on a population of apparently healthy subjects. Salud Pública de México. 2008;50(5):375–382. doi:10.1590/S0036-36342008000500010
   Web of Science ®Google Scholar
• Garg A, Garg V, Hegele RA, Lewis GF. Practical definitions of severe versus familial hypercholesterolaemia and hypertriglyceridaemia for adult clinical practice. Lancet Diabetes Endocrinol. 2019;7(11):880–886. doi:10.1016/S2213-8587(19)30156-1
   Web of Science ®Google Scholar
• Weiss FU, Laemmerhirt F, Lerch MM. Etiology and risk factors of acute and chronic pancreatitis. Visc Med. 2019;35(2):73–81. doi:10.1159/000499138
   PubMed Web of Science ®Google Scholar
• Hegele RA, Pollex RL. Hypertriglyceridemia: phenomics and genomics. Mol Cell Biochem. 2009;326(1–2):35–43. doi:10.1007/s11010-008-0005-1
   PubMed Web of Science ®Google Scholar
• Chyzhyk V, Brown AS. Familial chylomicronemia syndrome: a rare but devastating autosomal recessive disorder characterized by refractory hypertriglyceridemia and recurrent pancreatitis. Trends Cardiovasc Med. 2019;S1050–738(19)30030–1.
   Web of Science ®Google Scholar
• Cox DW, Breckenridge WC, Little JA. Inheritance of apolipoprotein C-II deficiency with hypertriglyceridemia and pancreatitis. N Engl J Med. 1978;299(26):1421–1424. doi:10.1056/NEJM197812282992601
   Web of Science ®Google Scholar
• D’Erasmo L, Di Costanzo A, Cassandra F, et al. Spectrum of mutations and long-term clinical outcomes in genetic chylomicronemia syndromes. Arterioscler Thromb Vasc Biol. 2019;39(12):2531–2541. doi:10.1161/ATVBAHA.119.313401
   PubMed Web of Science ®Google Scholar
• Surendran RP, Visser ME, Heemelaar S, et al. Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridemia. J Intern Med. 2012;272(2):185–196. doi:10.1111/j.1365-2796.2012.02516.x
   PubMed Web of Science ®Google Scholar
• Chokshi N, Blumenschein SD, Ahmad Z, Garg A. Genotype-phenotype relationships in patients with type I hyperlipoproteinemia. J Clin Lipidol. 2014;8(3):287–295. doi:10.1016/j.jacl.2014.02.006
   PubMed Web of Science ®Google Scholar
• Brahm AJ, Hegele RA. Chylomicronemia-current diagnosis and future therapies. Nat Rev Endocrinol. 2015;11(6):352–362. doi:10.1038/nrendo.2015.26
   PubMed Web of Science ®Google Scholar
• Wolska A, Dunbar RL, Freeman LA, et al. Apolipoprotein C-II: new findings related to genetics, biochemistry, and role in triglyceride metabolism. Atherosclerosis. 2017;267:49–60. doi:10.1016/j.atherosclerosis.2017.10.025
   PubMed Web of Science ®Google Scholar
• Breckenridge WC, Little JA, Steiner G, Chow A, Poapst M. Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N Engl J Med. 1978;298(23):1265–1273. doi:10.1056/NEJM197806082982301
   PubMed Web of Science ®Google Scholar
• Xiong WJ, Li WH, Posner I, et al. No severe bottleneck during human evolution: evidence from two apolipoprotein C-II deficiency alleles. Am J Hum Genet. 1991;48(2):383–389.
   Web of Science ®Google Scholar
• Okubo M, Toromanovic A, Ebara T, Murase T. Apolipoprotein C-II Tuzla: a novel large deletion in APOC2 caused by Alu-Alu homologous recombination in an infant with apolipoprotein C-II deficiency. Clin Chim Acta. 2015;438:148–153. doi:10.1016/j.cca.2014.08.022
   PubMed Web of Science ®Google Scholar
• Widholm O, Kantero RL, Axelson E, Johansson ED, Wide L. Endocrine changes before and after the menarche. I. Urinary excretion of estrogen, FSH and LH, and serum levels of progesterone, FSH and LH. Acta Obstet Gynecol Scand. 1974;53(3):197–208. doi:10.3109/00016347409162157
   Web of Science ®Google Scholar
• Aljenedil S, Hegele RA, Genest J, Awan Z. Estrogen-associated severe hypertriglyceridemia with pancreatitis. J Clin Lipidol. 2017;11(1):297–300. doi:10.1016/j.jacl.2016.12.006
   PubMed Web of Science ®Google Scholar
• Connelly PW, Maguire GF, Little JA. Apolipoprotein CIISt. Michael. Familial apolipoprotein CII deficiency associated with premature vascular disease. J Clin Invest. 1987;80(6):1597–1606. doi:10.1172/JCI113246
   Web of Science ®Google Scholar
• Jiang J, Wang Y, Ling Y, Kayoumu A, Liu G, Gao X. A novel APOC2 gene mutation identified in a Chinese patient with severe hypertriglyceridemia and recurrent pancreatitis. Lipids Health Dis. 2016;15:12. doi:10.1186/s12944-015-0171-6
   Web of Science ®Google Scholar
• De Pretis N, Amodio A, Frulloni L. Hypertriglyceridemic pancreatitis: epidemiology, pathophysiology and clinical management. United Eur Gastroenterol J. 2018;6(5):649–655. doi:10.1177/2050640618755002
   PubMed Web of Science ®Google Scholar
• Gelrud A, Whitcomb D. Hypertriglyceridemia-induced acute pancreatitis. In: UpToDate, Friedman L, editor. Waltham: UpToDate Inc; 2019.
   Google Scholar
• Gubensek J, Buturovic-Ponikvar J, Romozi K, Ponikvar R, Rakonczay Z. Factors affecting outcome in acute hypertriglyceridemic pancreatitis treated with plasma exchange: an observational cohort study. PLoS One. 2014;9(7):e102748. doi:10.1371/journal.pone.0102748
   PubMed Web of Science ®Google Scholar
• Shirakawa T, Nakajima K, Shimomura Y, et al. Comparison of the effect of post-heparin and pre-heparin lipoprotein lipase and hepatic triglyceride lipase on remnant lipoprotein metabolism. Clin Chim Acta. 2015;440:193–200. doi:10.1016/j.cca.2014.07.020
   Web of Science ®Google Scholar
• Witztum JL, Gaudet D, Freedman SD, et al. Volanesorsen and triglyceride levels in familial chylomicronemia syndrome. N Engl J Med. 2019;381(6):531–542. doi:10.1056/NEJMoa1715944
   PubMed Web of Science ®Google Scholar